T cells are very potent cancer-fighting cells in our immune system, and are often used in cell-based immunotherapies. Dr. Gerlach is helping to decipher their various identities and behaviors. She is searching for markers on the T cells that delineate cells with different functional properties.
Harvard Medical School | All Cancers | 2014 | Ulrich H. von Andrian, M.D.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Meet three promising young scientists changing the face of immuno-oncology: Ryan K. Alexander, Ph.D., of Boston Children’s Hospital; Nelson M. LaMarche, Ph.D., of the Icahn School of Medicine at Mount Sinai; and Christopher B. Medina, Ph.D., of Emory University.
New research, new treatments, and how we’re working toward a future immune to cervical cancer